Name | Recombinant Mouse BAFF R/TNFRSF13C Fc Chimera Protein, CF |
---|---|
Supplier | R&D Systems |
Catalog | 1357-BR |
Category | Protein |
Prices | $339.00 |
Sizes | 50 µg |
Species Reactivities | Mouse |
Nature | Recombinant |
Source | Mouse myeloma cell line, NS0-derived Mouse BAFF R (Ser10-Ala 71) Accession # Q9D8D0 DIEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus |
Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Bioactivity | Measured by its ability to inhibit BAFF-mediated proliferation of anti-IgM stimulated mouse B cells. Gross, J.A. et al . (2000) Nature 404 :995. The ED 50 for this effect is 2-6 ng/mL in the presence of 3 ng/mL of rmBAFF. |
Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
SwissProt/Accession | Q9D8D0 |
Gene | Tnfrsf13c |
Sequence | Ser10 |
Supplier Page | Shop |
Hagglof T, Sedimbi SK, Yates JL, Parsa R, Salas BH, Harris RA, Leadbetter EA, Karlsson MC. Nat Immunol. 2016 Dec;17(12):1407-1414.
Gatjen M, Brand F, Grau M, Gerlach K, Kettritz R, Westermann J, Anagnostopoulos I, Lenz P, Lenz G, Hopken UE, Rehm A. Cancer Res. 2016 Sep 15;76(18):5253-65.
Hong C, Qiu X, Li Y, Huang Q, Zhong Z, Zhang Y, Liu X, Sun L, Lv P, Gao XM. J Immunol. 2010 Oct 15;185(8):4561-9.
Matsushita T, Fujimoto M, Hasegawa M, Matsushita Y, Komura K, Ogawa F, Watanabe R, Takehara K, Sato S. J Invest Dermatol. 2007 Dec;127(12):2772-80. Epub 2007 Jun 21.